Pharmacodiagnostics is swiftly emerging as a vital player in the global cancer diagnostics market, which soared to nearly $10 billion in revenue in 2024, according to Kalorama Information’s recent report, The World Market for Cancer Diagnostics, 2024-2029. This dynamic sub-segment is experiencing rapid growth, fueled by the increasing affordability of next-generation sequencing (NGS), which offers profound […]
This blog draws on insights from the Kalorama Information report, In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029. For further details, please visit the report’s product page HERE. Personalized medicine, also known as precision medicine, is revolutionizing the healthcare landscape. This innovative approach tailors medical treatment to the individual characteristics of […]
In a rapidly evolving healthcare landscape, staying ahead in the field of in vitro diagnostics (IVD) is more crucial than ever. This blog delves into key insights from Kalorama Information’s latest market research report, In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029. As the fifth installment in Kalorama’s North American IVD […]
Welcome to our latest blog, created in collaboration with The Scott Partnership Ltd., a renowned UK-based global marketing and communications agency specializing in the life sciences, healthcare, and technology sectors. Originally published on their platform, this blog marks the beginning of an exciting ongoing partnership with more blogs to come. In Vitro Diagnostics Business Outlook’s […]
The global market for in vitro diagnostic (IVD) laboratory coagulation products is forecast to grow steadily, driven by the increasing volume of surgical procedures, the widespread adoption of enhanced post-surgical monitoring activities, and increasing applications in surgical, inpatient, and emergency care settings. According to the October 2024 market report IVD Test Procedure Volumes, 2024-2029 by […]
Immunoassays, which are tests based on the binding of antibodies to antigens to identify the presence of a substance (an analyte), have been a cornerstone of clinical lab medicine since the mid-1960s. These tests, whether automated, manual, ELISAs, enzyme immunoassays, bead arrays, microarrays, or those using mass spectrometry, play a dominant role in laboratory medicine. […]
Histology and cytology, foundational pillars of pathological labs, play a critical role in diagnosing a variety of diseases, including cancer. With innovations enhancing diagnostic accuracy, efficiency, and patient outcomes, the industry is poised for significant growth and transformation in the coming years. In the report, Histology and Cytology IVD Market Update, 2024, Kalorama Information’s research […]
In 2023, point-of-care (POC) diagnostic testing market sales reached $36.8 billion, fueled by both professional and self-testing, according to Kalorama Information’s April 2024 report The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11th Edition. The POC diagnostic testing market continues to expand thanks to emerging technologies and increasing demand that will drive growth into the […]
Artificial intelligence (AI) is growing at a fast pace due to the adoption of AI-based technologies. There is a move toward connected health, which includes AI. AI has proved to be an invaluable tool in assisting physicians in caring for their patients. The advanced capabilities of algorithms are serving to reduce workloads and provide testing […]
The global market for lab-based immunoassays, inclusive of both infectious disease and non-infectious disease analytes and instruments, reached $27 billion in 2023 and is forecast to experience modest growth in the foreseeable future. The findings are based on data published in In Vitro Diagnostics Business Outlook, 2024, a bi-monthly newsletter focused on global IVD products […]
